These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35328862)

  • 1. Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review.
    Fearby N; Penman S; Thanos P
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice.
    Eitan A; Gover O; Sulimani L; Meiri D; Schwartz B
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.
    Pintori N; Caria F; De Luca MA; Miliano C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol.
    Rao Q; Zhang T; Dai M; Li B; Pu Q; Zhao M; Cheng Y; Yan D; Zhao Q; Wu ZE; Li F
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
    Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
    J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of daily Δ
    Withey SL; Kangas BD; Charles S; Gumbert AB; Eisold JE; George SR; Bergman J; Madras BK
    Drug Alcohol Depend; 2021 Apr; 221():108629. PubMed ID: 33640678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What Do You Know About Maryjane? A Systematic Review of the Current Data on the THC:CBD Ratio.
    Zeyl V; Sawyer K; Wightman RS
    Subst Use Misuse; 2020; 55(8):1223-1227. PubMed ID: 32124675
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
    Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
    Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT
    Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
    Bhattacharyya S; Fusar-Poli P; Borgwardt S; Martin-Santos R; Nosarti C; O'Carroll C; Allen P; Seal ML; Fletcher PC; Crippa JA; Giampietro V; Mechelli A; Atakan Z; McGuire P
    Arch Gen Psychiatry; 2009 Apr; 66(4):442-51. PubMed ID: 19349314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats.
    Gabaglio M; Zamberletti E; Manenti C; Parolaro D; Rubino T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis and Its Permissibility Status.
    Alzeer J; Hadeed KA; Basar H; Al-Razem F; Abdel-Wahhab MA; Alhamdan Y
    Cannabis Cannabinoid Res; 2021 Dec; 6(6):451-456. PubMed ID: 33998850
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Cavalheiro EKFF; Costa AB; Salla DH; Silva MRD; Mendes TF; Silva LED; Turatti CDR; Bitencourt RM; Rezin GT
    Cannabis Cannabinoid Res; 2022 Apr; 7(2):135-151. PubMed ID: 34242511
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.